Spelling suggestions: "subject:"ischemia preconditions""
11 |
An Ischemic β-Dystroglycan (βDG) Degradation Product: Correlation With Irreversible Injury in Adult Rabbit CardiomyocytesArmstrong, Stephen C., Latham, Carole A., Ganote, Charles E. 01 January 2003 (has links)
A loss of sarcolemmal dystrophin was observed by immuno-fluorescence studies in rabbit hearts subjected to in situ myocardial ischemia and by immuno-blotting of the Triton soluble membrane fraction of isolated rabbit cardiomyocytes subjected to in vitro ischemia. This ischemic loss of dystrophin was a specific event in that no ischemic loss of sarcolemmal α-sarcoglycan, γ-sarcoglycan, αDG, or βDG was observed. The maintenance of sarcolemmal βDG (43 Kd) during ischemia was interesting in that dystrophin binds to the C-terminus of βDG. However, during late in vitro ischemia, a 30 Kd band was observed that was immuno-reactive for βDG. Additionally, this 30 Kd-βDG band was observed in rabbit myocardium subjected to autolysis. Finally, the 30 Kd-βDG was observed in the purified sarcolemmal fraction of rabbit cardiomyocytes subjected to a prolonged period of in vitro ischemia, confirming the sarcolemmal localization of this band. The potential patho-physiologic significance of this band was indicated by the appearance of this band at 120-180 min of in vitro ischemia, directly correlating with the onset of irreversible injury, as manifested by osmotic fragility. Additionally the appearance of this band was significantly reduced by the endogenous cardioprotective mechanism, in vitro ischemic preconditioning, which delays the onset of osmotic fragility. In addition to dystrophin, βDG binds caveolin-3 and Grb-2 at its C-terminus. The presence of Grb-2 and caveolin-3 in the membrane fractions of oxygenated and ischemic cardiomyocytes was determined by Western blotting. An increase in the level of membrane Grb-2 and caveolin-3 was observed following ischemic preconditioning as compared to control cells. The formation of this 30 Kd-βDG degradation product is potentially related to the transition from the reversible to the irreversible phase of myocardial ischemic cell injury and a decrease in 30 Kd-βDG might mediate the cardioprotection provided by ischemic preconditioning.
|
12 |
Concentration-Response Relationships for Adenosine Agonists During Preconditioning of Rabbit CardiomyocytesRice, Peter J., Armstrong, Stephen C., Ganote, Charles E. 01 January 1996 (has links)
Although adenosine receptors have been implicated in the induction of preconditioning in a variety of experimental models, there is controversy concerning the specific adenosine receptor subtypes mediating this effect. Concentration-protection relationships for adenosine and adenosine agonists in rabbit cardiomyocytes were used to characterize the role of adenosine receptor subtypes in preconditioning. Isolated cells were ischemically preconditioned or pre-incubated for 10 min with increasing concentrations of adenosine, CCPA (2-chloro-N6-cyclopentyladenosine) APNEA (N6-2-(4-aminophenyl)ethyladenosine), or BNECA (N6-benzyl-5'-N-ethyl-carboxamidoadenosine) in the presence or absence of 1 or 10 μM of the selective A1-adenosine antagonist DPCPX (8-Cyclopentyl-1,3-dipropylxanthine). Following a 30-min post-incubation period, cells were pelleted, layered with oil and ischemically incubated for 180 min. Injury was assessed by osmotic swelling and trypan blue exclusion of sequential samples, and determination of the areas beneath the mortality curves. Adenosine produced a broad concentration-protection curve which was displaced to the right by DPCPX. The curve for A1-selective agonist CCPA was biphasic, with an initial response below 1 nM and a second above 1 μM. DPCPX abolished the early response leaving a steep monophasic curve between 0.1 and 10 μM CCPA. The APNEA curve appeared monophasic, the major slope occurring between 1-100 nM; DPCPX (1 μM) shifted the concentration-response curve ≃ 30-fold and decreased the slope. Adenosine receptor agonist BNECA produced preconditioning characterized by a shallow monophasic concentration-protection curve with a maximal effect of 49% and an EC50 of ≃ 5 nM; DPCPX shifted the BNECA concentration-protection relationship ≃ 40-fold with only a modest increase in slope. Analysis of the data suggests that induction of preconditioning results from interaction of agonists with the A1 receptor and a second adenosine receptor having properties consistent with the A3 receptor. Adenosine, CCPA, APNEA, BNECA and DPCPX each appear to be selective for the A1 adenosine receptor subtype in isolated rabbit cardiomyocytes.
|
13 |
The Effect of Ischemic Preconditioning on Repeated Supramaximal SprintsBarr, Marcus W. 26 July 2011 (has links)
No description available.
|
14 |
Ação de opióides, isquemia intermitente e treinamento físico na redução da área de infarto do miocárdio experimental em ratos / Effects of opioids, transient ischemia, and exercise training on reduction of myocardial infarction area in ratsGalvão, Tatiana de Fatima Gonçalves 08 August 2007 (has links)
INTRODUÇÃO: Baseados em estudo que evidenciou menor área de infarto do miocárdio (IM) em ratos submetidos a treinamento físico (TF),na ausência de reperfusão; e na liberação de endorfinas que ocorre durante o TF, nossos objetivos são: demonstrar se não só TF, mas também opióides e isquemia/reperfusão (IR) intermitente são capazes de reduzir área de IM, na ausência de reperfusão; se TF e opióides exibem efeito sinérgico e se o mecanismo de redução da área de IM pelo TF envolve receptores opióides. MATERIAIS E MÉTODOS: Ratos Wistar machos (n=76) foram divididos em 7 grupos:1- controle;2- TF (esteira elétrica,1 hora/dia,5 vezes/semana,por 12 semanas), antes do IM; 3- morfina antes do IM; 4- morfina+TF; 5- grupo com 3 ciclos de IR antes do IM; 6- naloxone antes da morfina; 7- naloxone antes de cada dia de TF. Todos os ratos foram submetidos à mensuração da pressão diastólica final (PDF) e a IM através da oclusão da artéria descendente anterior. A eficácia do TF foi avaliada através do consumo de oxigênio (VO2) e da distância máxima percorrida. Os ratos foram sacrificados no 8o pós-IM e a área de IM mensurada por planimetria. RESULTADOS: Não houve diferença no peso inicial (p=0,94), mortalidade (p=0,99), e relação peso cardíaco/peso corporal (p=0,29) entre os grupos. Entretanto, houve aumento do deltaVO2 (VO2 pico - VO2repouso) (p=0,0001)e da distância máxima percorrida (p=0,0001), nos grupos treinados. A PDF aumentou no pós-IM, em todos os grupos (p=0,0001). Os grupos tratados tiveram menor área de IM (p=0,0001), com exceção dos grupos morfina + naloxone e TF+ naloxone sendo que não houve maior redução no grupo TF+morfina. Os grupos TF e TF+morfina apresentaram maior espessura do septo inter-ventricular, em relação ao grupo controle (p=0,0008). Já o grupo TF + naloxone não apresentou maior espessura do septo IV, em relação aos outros grupos. Também não houve diferença na densidade capilar (p=0,88). CONCLUSÃO: Não só TF, mas também morfina e IR reduzem a área de IM, na ausência de reperfusão, sendo que não há efeito sinérgico entre TF e morfina. Esta redução não ocorre através do aumento da densidade capilar. Além disto, a ação do TF sobre a área de IM provavelmente ocorre através do estímulo de receptores opióides, visto que seu bloqueio anulou o efeito cardioprotetor do TF / BACKGROUND AND OBJECTIVES: Studies have shown a decrease in infarcted area in rats submitted to exercise training (ET), in the absence of reperfusion. Based on that, we tested four hypotheses: 1- not only ET but also another stimulus that causes myocardial protection, like opioid infusion and brief periods of ischemia-reperfusion (IR) before irreversible left anterior descending (LAD) coronary occlusion could reduce infarct area, 2- ET plus opioid infusion could have additive effects in reducing infarct size, 3- blocking the opioid system we could lose the myocardial protection caused by ET, 4-myocardial protection given by different strategies could occur due to the increase in capillary density. METHODS: Male Wistar rats (n=76) were randomly assigned to 7 groups: control (n=11); ET (n=12); morphine infusion before myocardial infarction (MI) (n=14); ET plus morphine (n=11); naloxone (a non selective opioid receptor blocker) plus morphin (n=9); intermittent IR (n=12) before MI; naloxone before each ET session (n=7). All groups were submitted to MI by LAD ligation technique and to measurement of left ventricular end-diastolic pressure (LVEDP) before and 5 min after MI. ET was performed on a treadmill for 60 min, 5 times/week for 12 weeks at 60% peak oxygen (peak VO2). To evaluate the efficacy of ET, we tested the exercise capacity and the peak VO2 before and after experimental period. Seven days after MI induction, rats were killed and hearts were harvested. Infarct size was expressed by evaluation of necrotic area, expressed as a % of the risk region (total left ventricle area). RESULTS: There were no differences in initial weight, cardiac/animal weight or mortality among groups. Exercise training increased exercise capacity (p=0.0001) and delta VO2 (VO2 peak-VO2 rest) (p=0.0001). Inter-ventricular septum thickness was higher in the ET and ET plus morphine groups, compared to the control group (p=0.0008). The LVEDP increased in the post-MI period, for all groups (p=0.0001). All treatment groups but not morphine plus naloxone and ET plus naloxone showed a decrease in infarcted area (p=0.0001). There was no additional decrease in infarct size in the ET+ morphine group, comparing with each group alone . There was no difference in capillary density for all groups. CONCLUSION: Not only ET, but also morphine and IR decrease infarcted area, in the absence of reperfusion. There is no additional effect between ET and morphine. Moreover, this reduction is not due to an increase in capillary density. The effect of ET in decreasing infarct size might occur by opioid receptor stimulus
|
15 |
Efeito da repaglinida sobre o pré-condicionamento isquêmico / The effect of repaglinide on ischemic preconditioningBetti, Roberto Tadeu Barcellos 16 May 2007 (has links)
Introdução: O aumento da tolerância do miocárdio isquêmico observado durante o segundo de dois testes de esforços seqüenciais, o fenômeno do pré-aquecimento, foi proposto como um modelo clínico do pré-condicionamento isquêmico. Bloqueadores dos canais de K-ATP dependentes, tais como as sulfoniluréias, podem induzir a perda do pré-condicionamento isquêmico, o qual poderia estar envolvido no aumento dos eventos cardiovasculares. A repaglinida é um agente hipoglicemiante oral, pertencente à família da meglitinida e supostamente dotada de menor efeito no pré-condicionamento isquêmico, ainda que o fármaco tenha seu principal mecanismo de ação nos canais de K-ATP dependentes. Objetivos e Métodos: O objetivo foi investigar os efeitos da repaglinida no fenômeno do pré-condicionamento isquêmico em pacientes diabéticos com doença coronariana estável. Foram estudados 42 pacientes diabéticos tipo 2, com angina estável e doença arterial documentada. Todos os pacientes tinham testes ergométricos positivos para isquemia. Na primeira fase do teste, a sulfoniluréia e os betabloqueadores foram suspensos por trinta dias e sete dias, respectivamente. Os pacientes foram submetidos a dois testes ergométricos seqüenciais, com intervalo de trinta minutos (testes 1 e 2). Na segunda fase, os pacientes receberam repaglinida por sete dias e mais dois testes ergométricos foram repetidos (testes 3 e 4). Resultados: Todos os pacientes alcançaram ST >1 mm na primeira fase (Teste 1 e 2). O tempo alcançado no teste 2 foi maior que aquele alcançado no teste 1 (4:44s. x 5:37s. p=0,001), como também foi maior a duração do exercício (6:15s x 6:29s. p=0,008), denotando pré-condicionamento isquêmico. Após o uso da repaglinida, nos testes 3 e 4, observou-se menor tempo alcançado para atingir isquemia no teste 4 (5:37s. x 4:58s. p=0,001). Observou-se, ainda, menor tempo de tolerância ao exercício na fase 2 (6:57s x 6:34s. p=0,007). Em relação ao surgimento de angina, não se constataram diferenças estatísticas entre as duas fases. Conclusão: Nos pacientes diabéticos com doença coronariana estável, a repaglinida bloqueou o pré-condicionamento isquêmico. / Background: The increase of tolerance to myocardial ischemia observed during the second of two sequential exercise tests, the warm-up phenomenon, has been proposed as a clinical model of ischemic preconditioning. Blockers of K-ATP channels, such as the Sulfonylurea drugs, can induce loss of ischemic preconditioning, what could be involved in an increase of cardiac events. Repaglinide is a hypoglycemic agent with supposedly lower influence on ischemic preconditioning, despite acting in K-ATP channels. Objectives and Methods: This study investigated the effects of repaglinide on the ischemic preconditioning in diabetic patients with CAD. There were 42 patients and inclusion criteria were positive treadmill test for myocardial ischemia. Sulphonylureas and beta-blocking agents were withdrawn 30 and 7 days respectively before phase 1 of the study. In this phase, the patients underwent two consecutive treadmill exercise tests at 30 minute intervals (test 1 and test 2). In phase 2 of the study, all patients received repaglinide 2 mg three times daily during 7 days before treadmill exercise test (test 3 and test 4). Results: All patients achieved 1.0 mm ST-segment depression during phase 1. The time achieved to ST depression during test 2 was greater than that during test 1 (4:44s vs. 5:37s. p=0.001) as well as the duration of the exercise (6:15s vs.6: 29s. p=0.008), suggesting a higher ischemic threshold. In phase 2 after repaglinide, all patients achieved 1 mm ST-segment depression. However, the time achieved to ST depression, as well as the duration of the exercise, was lower in test 4 comparing with test 3. There were no statistical differences regarding angina episodes in phase 1 or phase 2. Conclusions: In diabetic patients with stable coronary disease, the oral hypoglycemic agent repaglinide abolished the myocardial ischemic preconditioning.
|
16 |
Isoform specific effect of ischemia/reperfusion on cardiac Na,K-ATPase : protection by ouabain preconditioningStebal, Cory. January 2009 (has links)
Thesis (M.S.)--University of Toledo, 2009. / "In partial fulfillment of the requirements for the degree of Master of Science in Biomedical Science." Title from title page of PDF document. Bibliography: p. 39-48.
|
17 |
Analgetic and algetic effects of adenosine in healthy volunteers and patients with coronary artery disease /Sadigh, Bita, January 2007 (has links)
Diss. (sammanfattning) Stockholm : Karolinska institutet, 2007. / Härtill 5 uppsatser.
|
18 |
Time dependency in the protection from myocardial injury after myocardial ischemia and reperfusion : new insights from experimental studies with the ultrashort-acting calcium antagonist clevidipine /Segawa, Daisuke, January 2002 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2002. / Härtill 5 uppsatser.
|
19 |
The effect of diazoxide upon heat shock protein expression and physiological response to hemorrhagic shock and cerebral strokeO'Sullivan, Joseph C. January 2006 (has links) (PDF)
Thesis (Ph. D.)--Uniformed Services University of the Health Sciences, 2006. / Typescript (photocopy).
|
20 |
Análise de marcadores inflamatórios e antioxidantes após aplicação das técnicas de hipotermia tópica e pré-condicionamento isquêmico na lesão de isquemia e reperfusão hepática em ratosLongo, Larisse January 2014 (has links)
Introdução: A hipotermia tópica (HT) e o pré-condicionamento isquêmico (PCI) são métodos utilizados para diminuir a lesão de isquemia/reperfusão (I/R). A eficácia do uso concomitante da HT e PCI (HT+PCI) no fígado em relação à inflamação e à citoproteção antioxidante não está elucidada. Objetivo: Avaliar o processo inflamatório e os mecanismos de segunda linha de defesa antioxidante na lesão de I/R hepática em ratos em relação à utilização das técnicas de HT e PCI de forma isolada ou associada. Métodos: Ratos Wistar (n=32) foram submetidos à isquemia hepática parcial (70%) durante 90 minutos seguida por 120 minutos de reperfusão. Os animais foram alocados nos grupos sham (n=4), isquemia normotérmica (IN, n=7), PCI (n=7), HT (n=7) e HT+PCI (n=7). O PCI consistiu na aplicação consecutiva de 10 minutos de isquemia e reperfusão antes do insulto isquêmico. A HT foi induzida pela superfusão de solução salina a 26°C sobre os lobos isquêmicos. A eutanásia foi realizada ao término do experimento e as amostras foram coletadas para a realização das análises moleculares utilizando as técnicas de ELISA e Western Blot, com o objetivo de comparar os perfis pró-inflamatório, anti-inflamatório e antioxidante. Resultados: O grupo HT comparado ao grupo IN apresentou diminuição da concentração do fator de necrose tumoral (TNF)-α, interleucina (IL)-1β, IL-6 e IL-12 e um aumento dos níveis de IL-10. O grupo HT apresentou menor expressão da óxido nítrico sintase induzível (iNOS) e um aumento da expressão da óxido nítrico sintase endotelial (eNOS). A expressão da NAD(P)H quinone oxidoreductase-1 (NQO1) foi menor no grupo HT. O PCI não demonstrou diferença significativa em relação a esses marcadores quando comparado ao grupo IN. O grupo HT+PCI apresentou menor concentração de IL-12 e menor expressão da iNOS e NQO1, mas em relação a estas moléculas a utilização de HT isolada demonstrou um comportamento semelhante. O grupo HT+PCI apresentou maior expressão da Kelch-like ECH-associated protein (Keap)-1 e menor expressão do nuclear erythroid 2-related factor 2 (Nrf2) nuclear e citoplasmático em relação ao grupo IN. Conclusão: O método de HT foi eficaz na proteção contra a lesão inicial de I/R. O uso de PCI isolado desencadeou a ativação da segunda linha de defesa antioxidante. A aplicação combinada de HT+PCI não confere benefício adicional em relação ao processo inflamatório quando comparado ao grupo HT, mas apresenta a vantagem de evitar a ativação da segunda linha de defesa antioxidante. / Background: Topical hypothermia (TH) and ischemic preconditioning (IPC) are used to decrease ischemia/reperfusion (I/R) injury. The effectiveness of using concomitantly TH and IPC (TH+IPC) in liver, regarding inflammation and antioxidant cytoprotection, is lacking. Aim: To evaluate the process inflammatory and second-line antioxidant defense mechanisms in hepatic I/R injury in rats in relation to the use of techniques TH and IPC isolate or associated. Methods: Wistar rats (n=32) subjected to partial (70%) hepatic ischemia during 90 minutes followed by 120 minutes of reperfusion. Livers from the animals allocated in sham (n=4), normothermic ischemia (NI, n=7), IPC (n=7), TH (n=7) and TH+IPC (n=7) groups. IPC consisted of consecutive 10-minute periods of ischemia and reperfusion before the ischemic insult. TH was induced by the superfusion of cooled saline at 26oC onto the ischemic lobes. Euthanasia was undertaken exactly at the end of the experiment and samples were collected for molecular analyses by ELISA and Western Blot assays, aiming to compare pro-inflammatory, anti-inflammatory and antioxidant profiles. Results: Compared with NI, TH presented decreased tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6 and IL-12 concentrations and increased IL-10 levels. TH displayed lower inducible nitric oxide synthase (iNOS), higher endothelial nitric oxide synthase (eNOS) expressions. NAD(P)H-quinone oxidoreductase-1(NQO1) expression was also lower in TH. Isolate IPC showed no differences regarding all these markers compared to NI. TH+IPC showed decreased IL-12 concentration and reduced iNOS and NQO1 expressions, but regarding these molecules isolate TH behaved similarly. TH+IPC showed higher Kelch-like ECH-associated protein (Keap)-1 and diminished nuclear and cytosolic nuclear erythroid 2-related factor 2 (Nrf2) expressions than NI. Conclusion: TH was the effective method of protection against early I/R injury. Isolated IPC entailed triggering of second-line antioxidant defense enzymes. Combined TH+IPC seemed to confer no additional advantage over isolated TH in relation to the inflammatory process, but had the advantage of avoid activation second-line antioxidant defense enzymes.
|
Page generated in 0.1029 seconds